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Background: Current experimental models of critical limb ischemia are based on acute ischemia rather than on chronic
ischemia. Human peripheral vascular disease is largely a result of chromic ischemia. We hypothesized that a model of
chronic hindlimb ischemia would develop more collateral arteries, more blood flow, and less necrosis and inflammation
than would acute hindlimb ischemia. We therefore developed a rat model of chronic hindlimb ischemia and compared the
effects of chronic ischemia with those of acute ischemia on hindlimb skeletal muscle.
Methods: Acute or chronic ischemia was induced in 36 male Sprague-Dawley rats. Chronic ischemia caused blood flow, as
measured by laser Doppler scanning and confirmed by muscle oxygen tension measurements, to gradually decrease over
1 to 2 weeks after operation.
Results: Histologic analysis showed chronic hindlimb ischemia better preserved muscle mass and architecture and
stimulated capillary angiogenesis, while lacking the muscle necrosis and inflammatory cell infiltrate seen after acute
ischemia. Surprisingly, the chronic ischemia group recovered dermal blood flowmore slowly and less completely than did
the acute ischemia group, as measured by laser Doppler (0.66 0.02 vs 0.76 0.04, P< .05) and tissue oxygen tension
(0.61  0.06 vs 0.81  0.05, P < .05) at 40 days postoperatively. Consistent with poorer blood flow recovery, chronic
ischemia resulted in smaller diameter collateral arteries (average diameter of the five largest collaterals on angiogram was
0.01  0.0003 mm vs 0.013  0.0007 mm for acute, P < .005 at 40 days postoperatively). Acute ischemia resulted in
decreased tissue concentrations of vascular endothelial growth factor (VEGF) (0.96  0.23 pg/mg of muscle for acute
vs 4.4  0.75 and 4.8  0.75 pg/mg of muscle for unoperated and chronic, respectively, P < .05 acute vs unoperated),
and in increased tissue concentrations of interleukin (IL)-1 (7.3  4.0 pg/mg of muscle for acute vs undetectable and
1.7  1.6pg/mg of muscle for unoperated and chronic, respectively, P < 0.05 acute vs unoperated).
Conclusions: We describe here the first model of chronic hindlimb ischemia in the rat. Restoration of blood flow after
induction of hindlimb ischemia is dependent on the rate of arterial occlusion. This difference in blood flow recovery
correlates with distinct patterns of muscle necrosis, inflammatory cell infiltration, and cytokine induction in the ischemic
muscle. Differences between models of acute and chronic hindlimb ischemia may have important consequences for future
studies of mechanisms regulating arteriogenesis and for therapeutic approaches aimed at promoting arteriogenesis in
humans suffering from critical limb ischemia. (J Vasc Surg 2005;41:312-20.)
Clinical Relevance:Despite the substantial clinical differences between acute and chronic ischemia, researchers attempting
to develop molecular therapies to treat critical limb ischemia have only tested those therapies in experimental models of
acute hindlimb ischemia. We present here a novel model of chronic hindlimb ischemia in the rat. We further demonstrate
that when hindlimb ischemia is developed chronically, collateral artery development is poorer than when hindlimb
ischemia is developed acutely. These findings suggest that further tests of molecular therapies for critical limb ischemia
should be performed in chronic hindlimb ischemia models rather than in acute hindlimb ischemia models.Critical limb ischemia in humans is untreatable by
current catheter-based or surgical strategies in up to
150,000 patients every year in the United States.1 The
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312progression of atherosclerotic peripheral vascular occlusive
disease in these patients often leaves amputation as their
only option. Therefore, investigators have concentrated on
establishing a molecular therapy to increase the develop-
ment of new capillaries (angiogenesis) or to promote the
enlargement of pre-existing collateral vessels (arteriogen-
esis). Several promising molecules have been identified that
enhance angiogenesis or arteriogenesis (or both) in exper-
imental models of hindlimb ischemia.2-7 However, such
molecules have been less successful in randomized human
clinical trials.8-10 This lack of success in humans is likely to
be multifactorial, but one reason may be that current
experimental models do not reflect accurately chronic ath-
erosclerotic arterial occlusion.
Current experimental models of critical limb ischemia
rely on acute ischemia that is generated by ligating or
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Volume 41, Number 2 Tang et al 313excising the femoral artery.11-13 All three of the currently
identifiedmajor mechanisms that promote arteriogenesis—
change in shear stress within collateral arteries,14 inflamma-
tion,15-17 and endothelial progenitor cell recruitment18—
are likely to be triggered by the acute ischemia.
Acute arterial occlusion leads to a sudden pressure
gradient between the arteries within the proximal nonisch-
emic region and the arteries in the distal ischemic region.
This pressure gradient leads to increased flow and, thereby,
increased shear stress within the collateral arteries bypassing
the occlusion. Increased shear stress leads to early and late
changes in gene expression through shear stress responsive
elements.19,20
Inflammatory cells infiltrate into the nonischemic and
ischemic muscle in response to acute ischemia, and some
areas of ischemic muscle undergo necrosis. Monocytes and
macrophages are thought to play an important role in
arteriogenesis, possibly through the release of cytokines
such as monocyte chemotactic protein-1.2,15,17,21,22 The
infiltrating inflammatory cells or, potentially, endothelial
progenitor cells18 that invade in response to acute ischemia
may assist arteriogenesis and blood flow recovery in animal
models that rely on ligation or excision. As time passes, the
acutely ischemic muscle undergoes fibrosis and regenera-
tion.23,24
In humans, critical limb ischemia results mainly from
atherosclerosis gradually occluding arteries over a time span
of months to years. This gradual onset of ischemia allows
the muscle tissue of the leg to accommodate to the gradual
decrease in blood flow by adaptations in muscle fiber type
and energy metabolism.25 These adaptations allow the leg
muscles to avoid the necrosis, inflammation, and regener-
ation seen after acute ischemia. In addition, increases in
shear stress occur gradually rather than acutely, allowing
more time for collateral artery adaptation and develop-
ment.
A single study reported the use of ameroid constrictors
to gradually occlude the femoral artery, creating a state of
chronic hindlimb ischemia in rabbits.26 An ameroid con-
strictor consists of a stainless steel casing surrounding a
hygroscopic casein material that has an internal lumen. The
casein gradually absorbs water, thereby swelling and oc-
cluding the arterial lumen that it encases.
These constrictors have been used previously on pig
and dog coronary arteries to simulate atherosclerotic coro-
nary artery disease.27,28 However, no models of gradual
arterial occlusion leading to chronic hindlimb ischemia in
the rat have been reported. In addition, to our knowledge,
no prior studies have investigated how the rate of arterial
occlusion affects spontaneous arteriogenesis and blood
flow recovery in any vascular bed.
We hypothesized that chronic ischemia would induce
collateral arteries to develop more fully, blood flow to
return more completely, and muscle fibers to show less
necrosis and inflammation than would occur in response to
acute hindlimb ischemia. To test our hypothesis, we devel-
oped the first rat model of gradual arterial occlusion by
using ameroid constrictors. We then compared several dif-ferent outcome variables against those resulting from our
previously described acute critical hindlimb ischemia model
in the rat.23
MATERIALS AND METHODS
Animals. Forty-two male Sprague-Dawley rats (Si-
monsen, Gilroy, Calif) weighing 280 to 350 g were used.
The rats were housed in an environmentally controlled
room and were given chow and water ad libitum. The care
of the rats complied with the Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory Animal Re-
sources, Commission on Life Sciences, National Research
Council, Washington, DC, National Academy Press,
1996). All protocols were approved in accordance with the
Committee on Animal Research at the University of
California, San Francisco.
Study design. The rats were divided into two study
groups: acute hindlimb ischemia created by artery liga-
tion23 (n  18) and chronic hindlimb ischemia created by
ameroid constrictors (n  18). Laser Doppler perfusion
imaging was performed serially at intervals of 3 to 4 days
throughout the duration of the study. The rats were also
studied on days 3, 14, and 40 postoperatively to measure
oxygen tension in the gastrocnemius muscle, muscle
weights (n  6 per group), and histology (n  3 per
group). Angiograms were performed on three rats in each
group at each time point. Six rats were used for unoperated
controls.
Hindlimb ischemia. Hindlimb ischemia was created
in the acute ischemia group by ligation of the left common
iliac artery and left femoral artery and all their branches as
described.23,29 The chronic ischemia group had a similar
operation performed, but instead of ligating the left com-
mon iliac artery at the aortic bifurcation and the left femoral
artery above the saphenopopliteal bifurcation, a 0.75-mm
internal diameter ameroid constrictor was placed around
the artery at each location. These custom ameroid constric-
tors (Research Instruments SW, Escondido, Calif) were
sterilized with ethylene gas prior to implantation. No arte-
riotomies were performed. The right limb served as an
internal control for each rat.
Clinical ischemia index. All rats were observed every
3 to 4 days for a clinical assessment of ischemia based on a
previously published clinical ischemia index.23 The rats
were scored according to an ischemia grade scale (0 
normal, 1  pale foot, 2  pressure sores, and 3 
necrosis) and abnormal gait (limping or no limping). In
addition, after sacrifice, muscle mass wasmeasured to quan-
titate recovery for a surrogate marker of muscle function.
Laser Doppler perfusion imaging. The rats were
anesthetized with 1% isoflurane with a constant oxygen
flow rate of 1 L/min and placed on a heating pad to
maintain a constant temperature. Hair was removed with
an electric shaver followed by Surgi-Prep depilatory cream
(Sparta Surgical, Roseville, Calif). A laser Doppler perfu-
sion imager (Moor Instruments, Ltd., Devon, UK) was
used to estimate dermal blood flow in the calf and foot.
Ratios of the operated–nonoperated limb were compared
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lighting.
Skeletal muscle oxygen tension. Muscle oxygen ten-
sion was measured by using Licox Clark-type oxygen and
temperature probes (Integra LifeSciences, Plainsboro, NJ)
in the left and right gastrocnemius at 3, 14, and 40 days
after operation, as described previously.23 A ratio of the left
limb–right limb was used for analysis.
Angiograms. Angiograms were performed as previ-
ously described.6,7 Briefly, the rats were anesthetized with
2% inhaled isoflurane. The infrarenal abdominal aorta was
ligated proximally and cannulated distally with a 20-gauge
polyethylene catheter. Warmed heparinized saline (10
U/mL, 4 mL total volume) was injected into the aortic
catheter. Barium sulfate (EZpaque) (0.6 g/mL, 2.5 mL
total volume) was then injected into the aortic catheter, and
the aorta and vena cava were ligated. The skin was removed
from the hindlimbs to avoid imaging the dermal vascula-
ture. Images were acquired by using a single enveloped
Kodak X-OMAT TL film at 500 mA, 50 kV, and 0.5-
second exposure. The rats were sacrificed prior to imaging.
Three blinded observers independently scored the im-
ages by counting the number of vessels that crossed a
standardized grid overlaying the image. The number of
vessels was then divided by the lines of the grid in the area
of interest to produce an angioscore. Vessel diameters were
measured using Fovea Pro software (Reindeer Graphics,
Inc, Asheville, NC) to analyze images digitally acquired by
scanning the angiographic films.
Tissue preparation. The rats were sacrificed after tis-
sue oxygen measurements and the gastrocnemius and tibi-
alis anterior from the right and left sides were harvested and
weighed for muscle mass. Middle sections of muscle were
processed into optimal cutting temperature compound
(Tissue-Tek, Fisher Scientific, Fairlawn, NJ) for morpho-
logic analysis to assess the extent of ischemic necrosis.
Hematoxylin and eosin stained sections were analyzed by
using Fovea Pro software (Reindeer Graphics, Inc) to mea-
sure the percent necrotic area of muscle sections. Immuno-
histochemistry was also performed to determine capillary
density.
Immunohistochemistry. Immunohistochemistry
was performed on muscle sections of the gastrocnemius
and tibialis anterior in three rats per group at each time
point. Capillary–muscle fiber ratios were determined by
staining for the endothelial-specific antigen CD31 (1:500
dilution, Serotec, Raleigh, NC) as described.23
Enzyme-linked immunosorbent assay. Commercially
available enzyme-linked immunosorbent assays (ELISA)
for VEGF, IL-1, and IL-6 were performed on homoge-
nized gastrocnemius (calf) and gracilis (thigh) muscle per
the manufacturer’s instructions (mouse VEGF Quantikine
ELISA kit, cross-reacts 70% with rat VEGF; rat IL-1
Quantikine ELISA kit; rat IL-6 Quantikine ELISA kit,
R&D Systems, Minneapolis, Minn).
Briefly, leg muscle harvested from sacrificed rats was
snap frozen in liquid nitrogen and pulverized by using a
prechilled mortar and pestle on dry ice. Approximately 100mg of eachmuscle was homogenized in 1.5mLNP-40 lysis
buffer (50 mM HEPES, pH 7.5; 150 mM NaCl, 10%
glycerol, 1.5 mMMgCl2, 1 mM EDTA, 100 mMNaF, 1%
NP-40) containing protease inhibitors (10 g/mL aproti-
nin, 10 g/mL leupeptin, and 1 mM 4-[2-aminoethyl]-
benzenesulfonyl-fluoride, hydrochloride [Pefabloc, Roche
Applied Science, Indianapolis, Ind]).
Muscle homogenates were centrifuged at 14,000 rpm.
The surface lipid layer was removed, and the supernatant
was saved at –80°C for ELISA and protein assay. Protein
concentration was measured by using a 1:500 dilution of
the supernatant in the microtiter plate micro-BCA protein
assay per themanufacturer’s instructions (Pierce, Rockford,
Ill). Supernatant dilutions of 1:5, 1:3, and 1:2 were used for
the VEGF, IL-1, and IL-6 ELISA assays, respectively.
Statistical analysis. All results are expressed as the
mean  standard error of the mean (SEM). Statistical
significance was determined using the unpaired Student t
test for comparison between two groups or analysis of
variance followed by Student-Newman-Keuls post-hoc
analysis for comparison among multiple groups. Differ-
ences in the clinical ischemia score were determined by the
Fisher exact test. A P value of 0.05 was considered to be
statistically significant.
RESULTS
Induction of ischemia. Critical limb ischemia was
induced by acute arterial occlusion but not by gradual
arterial occlusion according to the clinical ischemia index.
All rats in the acute ischemia group developed clinical signs
of critical limb ischemia, including pressure sores, muscle
atrophy, pale foot, and limping, with a maximum ischemia
index of 2 at 14 to 17 days and a final 40-day index of 1.
The rats in the chronic ischemia group never developed
signs of critical limb ischemia but did develop mild muscle
atrophy and pale feet (without limping), with a maximum
ischemia index of 1 at 40 days. A significant difference
was noted in the clinical ischemia index at 14days between the
acute and chronic groups (P 0.01 by the Fisher exact test).
Blood flow recovery. Chronic ischemia caused slower
and less complete blood flow recovery as measured by laser
Doppler perfusion imaging. Laser Doppler perfusion imag-
ing was used to measure blood flow in the foot and leg in
both treatment groups for up to the 40-day time point (Fig
1, A). For the rats in the acute ischemia group, blood flow
was lowest immediately postoperatively and recovered over
2 weeks to 60% of that measured in the unoperated leg.
During the next 2-week period, blood flow recovered more
slowly until the time of sacrifice on postoperative day 40,
achieving a final ratio of 66%. A different pattern of blood
flow recovery occurred in the rats in the chronic ischemia
group; blood flow was lowest, varying between 7 and 17
days postoperatively. Forty days after the induction of
ischemia, rats in the chronic ischemia group had a lower
foot dermal blood flow than those in the acute ischemia
group (0.66  0.02 vs 0.76  0.04, n  6 rats per group,
P  .04). Blood flow recovery in the calf in both groups
paralleled that in the foot (Fig 1, B).
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occlusion had lower gastrocnemius tissue oxygen tensions
than rats treated by acute arterial occlusion. In addition to
multiple determinations of dermal blood flow by laser
Doppler perfusion imaging, we directly measured tissue
oxygen tension in the gastrocnemius muscle on postoper-
ative days 3, 14, and 40 (Fig 1, C). These results were
consistent with those from laser Doppler blood flow mea-
surements. By postoperative day 40, rats in the acute isch-
emia group showed recovery of the gastrocnemius tissue
oxygen tension, as expressed as a left–right ratio, to 0.81
0.05; significantly higher than the 0.61  0.06 seen in the
chronic ischemia group (n 6 rats per group, P 0.033).
Muscle mass and architecture. The rats that were
treated by gradual arterial occlusion showed preserved
muscle mass and architecture without early muscle necrosis
or late fibrosis. The ischemic limb of the rats in the acute
ischemia group initially had greater calf muscle mass than
the contralateral side, secondary to edema (Fig 2, A).
Subsequently, muscle mass decreased secondary to muscle
necrosis and fibrosis (Fig 2, B). The gastrocnemius muscle
showed less fibrosis and more regeneration than the tibialis
anterior muscle, returning to normal muscle mass by post-
operative day 40 (Fig 2, B and C). The rats in the chronic
ischemia group had better preserved muscle mass (ratio of
left–right tibialis anterior muscle mass of 0.90  0.015 vs
0.51 0.077 at postoperative day 40, n 6 rats per group,
P  .005) and no evidence of the muscle necrosis, regen-
eration, or inflammatory cell infiltration seen after acute
ligation (Fig 2, A shows representative histology; Fig 2, C
shows muscle weights in the tibialis anterior muscle left
panel and gastrocnemius muscle right panel).
Angioscores and vessel diameter. Angioscores were
equivalent after acute and chronic ischemia, but vessel
diameter was greater in acute ischemia. Angioscores based
on the number of vessels were equivalent on postoperative
day 40, (Fig 3, A and B, left panel, 4.11  0.35 vs 4.57 
0.56, P  .52). However, the diameter of the largest five
vessels seen on each angiogram was greater in the acute
ischemia group than in the chronic ischemia group (Fig 3,
B, right panel, 0.013  0.0007 vs 0.010  0.0003, P 
.005). There was complete arterial occlusion at the site of
each ameroid constrictor in all rats studied by angiogram at
postoperative day 40.
Capillary counts. Capillary counts were increased
more by acute ischemia than by chronic ischemia. Although
capillary counts increased significantly in the rats in the
acute ischemia group (Fig 3, C left panel), the muscle fiber
number increased approximately the same amount, leaving
the capillary–muscle fiber ratio unchanged (Fig 3, C right
panel). The rats in the chronic ischemia group had in-
creased capillary–muscle fiber ratios when they were most
ischemic, as determined by tissue oxygen measurements
and laser Doppler perfusion ratios, on postoperative day
14. This ratio returned to normal by day 40, despite per-
sistent ischemia in the chronic ischemia group.
VEGF and inflammatory cytokines. VEGF de-
creased and inflammatory cytokines increased after acuteischemia but not after chronic ischemia. VEGF levels, as
detected by ELISA performed on muscle homogenates
from either the gastrocnemius (calf) or gracilis (thigh)
muscles, demonstrated a surprising decrease in the levels of
gastrocnemius muscle VEGF at postoperative days 3 and
14 in the acute ischemia group compared with unoperated
controls (Fig 4, A). However, levels of muscle IL-1 were
significantly higher in the acute ischemia group in both the
gracilis and gastrocnemius muscles at postoperative day 14
Fig 1. Hindlimb ischemia induced gradually leads to delayed foot
and calf blood flow recovery as determined by laser Doppler
perfusion imaging and persistent deficits in gastrocnemius tissue
oxygen tension. Blood flow is expressed as the ratio of the averaged
laser Doppler perfusion flux values of the left (ischemic) over the
right (nonischemic) foot (A) or calf (B) region. Laser Doppler
perfusion imaging was performed pre-operatively, postoperatively,
and every 3-4 days afterward out to 40-days postoperatively. C,
Tissue oxygen tension (pO2) was measured in the right and left
gastrocnemius muscles of rats anesthetized by pentobarbital at 3,
14, and 40 days postoperatively. The left–right ratio of gastrocne-
mius muscle oxygen tension correlated with the laser Doppler
perfusion ratio and was lower in the rats that underwent gradual
arterial occlusion than in the rats that underwent acutely arterial
occlusion (0.61  0.06 vs 0.81  0.05 respectively, *P  .05 vs
acutely induced ischemia group, n  6 rats per group.)(Fig 4, B). IL-6 levels trended higher at postoperative days
6 rat
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achieve statistically significance (Fig 4, C).
DISCUSSION
We created a novel model of chronic hindlimb ischemia
in the rat by using ameroid constrictors and used this model
to demonstrate significant differences in blood flow recov-
Fig 2. Chronic ischemia does not alter muscle architect
and eosin stained frozen sections of tibialis anterior muscl
or gradually. Other than mild perivascular edema at pos
seen in the chronic ischemia group. B, Pie graph demons
(TA) and gastrocnemius (GA) muscle sections harvested
seen in any muscle sections from the chronic ischemia
Gastrocnemius (GA) muscle weights after sacrifice (n ery, arteriogenesis, and morphologic outcomes of skeletalmuscle subjected to ischemia created acutely or gradually.
We demonstrated that rats implanted with ameroid con-
strictors reliably developed blood-flow deficits over the 1-
to 2-week period after operation and blood flow nadirs 7 to
17 days after the implantation of the constrictors.
Tissue oxygen content was decreased, and capillary
angiogenesis was stimulated transiently in response to this
r induce an inflammatory cell infiltrate. A,Hematoxylin
ested from rats that underwent arterial occlusion acutely
ative day 14, no changes in muscular architecture were
g the percentage of tissue fibrosis seen in tibialis anterior
stoperative day 40 after acute ischemia. No fibrosis was
(n  3 rats per group). C, Tibialis anterior (TA) and
s per group).ure o
e harv
toper
tratin
at po
groupischemia. Moreover, chronic ischemia did not result in
, n 
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to acute ischemia. Themore complete and rapid recovery of
blood flow seen after acute arterial occlusion may be due to
the inflammation that develops in response to the extensive
skeletal muscle necrosis, which was absent in chronic isch-
emia induced by gradual arterial occlusion using ameroid
constrictors.
A widely held clinical view is that the chronic onset of
ischemia due to peripheral vascular occlusive disease in-
duces greater collateral blood flow and less tissue injury
than acute ischemia due to trauma or thrombosis. Our
results suggest that gradual occlusion induces less tissue
injury but not greater collateral blood flow. The magnitude
of the differences in recovery of blood flow measured by
Fig 3. Chronic ischemia leads to similar collateral artery
acute ischemia. A, Representative angiograms on postop
or gradually. Vessel diameters are larger for rats that unde
days 3, 14, and 40 (n  3 rats per group per time poin
capillary-to-muscle fiber (MF) ratios (right panel) at pos
occlusion acutely or gradually. Unoperated gastrocnemi
comparison (*P  .05 vs unoperated, #P  .05 vs acutelaser Doppler, while not large was significant. Direct mea-surement of skeletal muscle oxygen tension showed an even
greater difference. We view the tissue oxygen data as more
precise than the laser Doppler-measured blood flow be-
cause it is a direct measurement of the level of oxygen
delivery to the ischemicmuscle as opposed to a proportional
measurement of dermal blood flow.
We speculate that the lack of inflammationmay account
for the slower recovery of blood flow in rats whose hind-
limb ischemia was created chronically rather than acutely.
In contrast, acute ischemia resulted in increased concentra-
tions of IL-1 and inflammatory cells seen by histology in
the gastrocnemius muscle. Profound muscle necrosis and
atrophy of the tibialis and gastrocnemius may have contrib-
uted to the initial rapid phase of blood flow recovery after
oscore but smaller diameter collateral arteries than does
e day 40 of rats that underwent arterial occlusion acutely
acute arterial occlusion.B,Angioscores at postoperative
Gastrocnemius capillary (CAP) counts (left panel) and
ative days 3, 14, and 40 for rats that underwent arterial
pillary count or capillary–muscle fiber ratio is shown for
3 rats per group per time point).angi
erativ
rwent
t). C,
toper
us caacute ischemia. Muscle necrosis may also explain the low
of acu
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muscle fibers contribute to muscle mass but not to VEGF
production.
Although not addressed in this study, an additional
possible mechanism explaining the slower recovery is that
much smaller pressure gradients developed19,20,30 between
the collateral arteries and the arteries in the ischemic limb in
the chronic ischemia group than occurred in the acute
ischemia group. These smaller pressure gradients might
contribute to decreased shear stress-responsive arterial re-
modeling affecting collateral artery development. In sup-
port of this were the significant differences between the
nadirs of blood flow, a mean of 0.14  0.02 in the acutely
induced group and 0.55  0.11 in the gradually induced
group, despite occlusion of the same set of arteries in both
groups.
It has previously been proposed that studying the later
Fig 4. Levels of vascular endothelial growth factor (VE
gracilis muscles differ after the induction of acute o
gastrocnemius (GC) muscle (left panel), and the left thig
levels decreased after the induction of acute ischemia (*P
acute ischemia group, n  3 rats per group per time po
ischemia than after chronic ischemia (*P 0.05 vs contr
point). C, IL-6 level trended higher after the inductionphases of recovery from experimental acute ischemia is asubstitute for chronic ischemia.31,32 Results from our study
demonstrate significant differences at the histologic and
cytokine level between ischemia induced chronically or
acutely. Histologically, after acute ischemia, necrotic mus-
cle fibers, the inflammatory cell infiltrate, and regenerating
myocytes can still be seen at postoperative day 14, and
fibrosis is still present at postoperative day 40. As this type
of tissue damage seen after acute ischemia can increase gene
transfer efficiency,33,34 models that use chronic ischemia
are more likely to reflect gene transfer efficiencies and
outcomes achievable in humans.
A shortcoming of our model of chronic ischemia is the
relatively short time between implantation and occlusion of
the ameroid constrictors. The period of 7 to 17 days prior
to blood flow nadir might be described as subacute rather
than chronic development of ischemia and may not be
sufficiently gradual enough to simulate accurately athero-
interleukin (IL)-1, and IL-6 in the gastrocnemius and
nic ischemia. Results are presented for the left calf
cilis (Gr) muscle (right panel) in A, B, and C. A,VEGF
05 vs control muscle from unoperated rats, #P  .05 vs
B, IL-1 levels are higher after the induction of acute
scle from unoperated rats, n 3 rats per group per time
te ischemia but this was not statistically significant.GF),
r chro
h gra
 .
int).
ol musclerotic occlusive disease that develops over years. None-
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seen in our model demonstrates that even a relatively short
period of time allows skeletal muscle to adapt to gradually
increasing ischemia and is sufficient to mitigate the harmful
effects of arterial occlusion.
A second shortcoming is that our model lacks the
inflammation in the arterial wall that is well known to be
associated with atherosclerotic plaques. This weakness
might be overcome by inducing chronic ischemia in a
mouse model of atherosclerosis, assuming that our findings
are not species or model specific and that our methods of
gradual arterial occlusion could be successfully adapted to
the mouse.
We report here the first rat chronic ischemia model
based on gradual arterial occlusion. We speculate that the
less complete recovery of limb blood flow and muscle
oxygen tension, but prevention of necrosis and preserva-
tion of muscle mass after chronic ischemia, may be due to
the absence of severe inflammation, necrosis, and high
shear rates in the collateral arteries in the hindlimb.
We further speculate that the severe inflammation,
necrosis, and high rates of shear stress occurring in experi-
mental models of acute hindlimb ischemia create a proar-
teriogenic environment. The lack of this proarteriogenic
environment in human peripheral vascular disease may
explain the failure of molecular therapies to adequately
reverse human critical limb ischemia.8-10
Finally, we suggest that animal models where ischemia
is generated chronically rather than acutely may be more
appropriate to study both molecular therapies for periph-
eral vascular disease and clinically relevant mechanisms of
collateral artery development.
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